InvestorsHub Logo

H2R

Followers 42
Posts 2158
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Friday, 05/05/2023 10:22:32 AM

Friday, May 05, 2023 10:22:32 AM

Post# of 12137
10 Commercial Therapies at the end of Q1 2023

As of the end of the first quarter, Cryoport supported 10 commercial therapies and a total of 652 clinical trials globally, with 82 of these in Phase 3. We expect up to an additional 18 anticipated application filings, 10 new therapy approvals and an additional 11 label or geographic expansion approvals in 2023.



https://seekingalpha.com/article/4600358-cryoport-inc-cyrx-q1-2023-earnings-call-transcript
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News